org placeholder image

Renee Perry

Sr. Manager, Cdm at Aimmune Therapeutics

  • LinkedIn

Email Email: r****@medtronic.com

phone noPhone Number: (***)-***-****

map
AIMMUNE THERAPEUTICS

AIMMUNE THERAPEUTICS

  • description Description
    Aimmune Therapeutics, Inc., a Nestle Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a m...

    Read More

  • Employees count Employees 501-1000
  • Revenue Revenue 1 Million to 5 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Aimmune Therapeutics Org Chart and Mapping

Employees

Jackie Koyama

Senior Manager, Payroll and Equity

Elsa Bonilla

Senior Clinical Trial Assistant

Sharilyn Treas

Clinical Trial Assistant

Robin Selsor

Director Strategic Accounts

Rhonda Ward

Biopharmaceutical Oral Immunotherapy; Community Liaison

Sharimen N

Quality Control Manager

Benjamin Blodgett

Associate Director, Market Access, Pricing and Contracting

Frequently Asked Questions Regarding Renee Perry

Answer: Renee Perry works for Aimmune Therapeutics as Sr. Manager, Cdm

Answer: Renee Perry’s role in Aimmune Therapeutics is Sr. Manager, Cdm

Answer: Renee Perry's email address is r***@gmail.com

Answer: Renee Perry's business email address is r****@medtronic.com

Answer: Renee Perry’s direct phone number is (***)-***-****

Answer: Renee Perry works in the industry of: Biotechnology

Answer: Renee Perry works Aimmune Therapeutics located at 8000 Marina BLVD Ste 300, Brisbane, California, 94005, United States

Answer: Aimmune Therapeutics's Sr. Manager, Cdm is Renee Perry

Answer: Renee Perry contact details:

  • Phone number  :  (***)-***-****
  • Email  :  r****@medtronic.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access